1. 108 CLINICAL FEATURES OF MYELODYSPLASTIC SYNDROME PATIENTS IN ONE CENTER IN NORTHWESTERN TURKEY. (April 2015) Authors: Pamuk, G.; Uyanik, M.; Maden, M.; Puyan, F. Oz; Demir, M. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 195 IMMUNE THROMBOCYTOPENIA IN MYELODYSPLASTIC SYNDROME WHICH WAS REFRACTORY TO ELTROMBOPAG WAS TREATED SUCCESSFULLY WITH RITUXIMAB. Issue 1 (April 2015) Authors: Pamuk, G.; Maden, M.; Uyanik, M.; Alptekin, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 235 COULD CHROMOSOMAL MOSAICISM PREDICT OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES?. Issue 1 (April 2015) Authors: Pamuk, G.; Uyanik, M.; Maden, M.; Gurkan, H.; Demir, M. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Diagnostic utility of NLR or PLR in predicting moderate/severe ovarian hyperstimulation syndrome: A biochemical aspect. (2nd January 2016) Authors: Sertoglu, E.; Kayadibi, H.; Uyanik, M. Journal: Journal of obstetrics and gynaecology Issue: Volume 36:Number 1(2016) Page Start: 70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗